Real-time, in vivo rodent imaging, allows researchers to observe and monitor several normal and abnormal biological processes. Data collected using the eyes™ series, provides crucial initial insights and generate quantitative results that, in combination with the Visual | eyes™  interface, compose an essential platform for every preclinical laboratory.

placeholder

Oncology

Non-invasively assess your agent's targeting properties, real-time monitor drug delivery and track tumor progression.

placeholder

Infection, Inflammation

Acquire detailed insights into disease mechanisms, enhance more accurate diagnostics while supporting the development or improvement of new or already existing therapeutics.

placeholder

Protocol optimization

Test different animal preparation conditions, drug concentrations and administration routes to optimize your protocols.

placeholder

Quick insights

Scan the same mouse at multiple time points to determine the optimal moments for 3D imaging. Conduct super-fast QC to exclude faulty injected subjects from further and more complex studies.

Applications with eyes™

Cardiac PET imaging

Cardiac PET

A preclinical platform to assess myocardial infarction therapies through non-invasive PET imaging

Cardiac PET imaging using ¹⁸F-FDG, in a mouse model of myocardial infarction

Image info: 80min post injection - 20min scan - total injected dose 6MBq

Assessing pulmonary biology

Planar imaging

Fast planar PET imaging across diverse preclinical applications

Rapid whole-body imaging across a range of preclinical applications

Image info: ⁸⁹Zr pulmonary contamination model – 24 h post administration – 5 min scan – 3.7 MBq administered activity
Study performed by the Chemical Sciences Division at LBNL, University of California, Berkeley

Special applications

Imaging of embryonic models

In ovo imaging using ¹⁸F-based tracer

Image info: 2h post injection - 10 min scan
Study performed by Theresa Balber et al. at Joint Applied Medicinal Radiochemistry Facility, Medical University of Vienna.

Back to top